ArticleBMC cancer2024

The Hippo pathway terminal effector TAZ/WWTR1 mediates oxaliplatin sensitivity in p53 proficient colon cancer cells.

Věra Slaninová et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.